Program Description:
Acute myeloid leukemia (AML) is the most common type of leukemia among adults. AML is a rapidly progressing cancer, and without treatment, most people with AML die within 3 to 4 month of diagnosis. With treatment, about one-third of patients with AML can be cured. Hematology/oncology clinicians have the opportunity to improve outcomes in patients with AML by expanding their awareness of new evidence-based practices and their ability to implement these practices. The goal of this CME activity is to increase knowledge and competency among hematology/oncology clinicians regarding best practices in the management of AML, ultimately improving complete remission rate and overall survival.
INTENDED AUDIENCE:
Hematologists, oncologists, and others interested in the care of patients with AML
Commercial Supporter:
This activity is supported by an educational grant from Boehringer Ingelheim.
Accredited Provider:
This activity is sponsored by Albert Einstein College of Medicine of Yeshiva University.
If you have any questions relating to the accreditation of this activity, please contact:
E-mail:
cme@montefiore.orgPhone 718-920-6677
Fax 718-798-2336
Instructions:
For full program information, please click on “BEGIN” button and follow the next click-through to reach this program site. Once you get to the “CMECorner” site description page, you will review program information, program content, take the test and receive credit.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.